"With a growing audience of savvy Baby Boomers and retirees seeking safe income ideas that deliver more than the 3.97% bi-annual dividend of the 10-year Treasury bond on a At 24/7 Wall St.,total return basis, we have screened hundreds of stocks. We are looking for recurring, dependable dividend payouts and a degree of safety that allows for a good night's sleep."
"Since 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciation has contributed 68%. Therefore, sustainable dividend income and capital appreciation potential are essential for total return expectations. A study by Hartford Funds, in collaboration with Ned Davis Research, found that dividend stocks delivered an annualized return of 9.18% over the past 50 years (1973-2023). Over the same timeline, this was more than double the annualized return for non-payers (3.95%)."
"All are the kind of stocks that growth and income investors can buy now, tomorrow, next week, or next year and hold for forever. All are rated Buy at top Wall Street firms that we cover here at 24/7 Wall St. Why do we cover quality dividend stocks? Since 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciation has contributed 68%."
Fifteen years of tracking dividend-paying stocks produced screening of hundreds of stocks for recurring, dependable dividend payouts and sufficient safety for sleep-at-night investing. Five companies were selected as lifelong buy-and-hold dividend stocks that balance stability, growth potential, diversification, and dividend reliability. All five companies carry Buy ratings from major Wall Street firms. Dividends have contributed roughly 32% of S&P 500 total return since 1926, and dividend payers delivered an annualized 9.18% return from 1973–2023 versus 3.95% for non-payers. AbbVie is highlighted with products including Humira, Skyrizi, Rinvoq, and Imbruvica.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]